KIF5A and amyotrophic lateral sclerosis: In this scenario, preliminary screening for variants associated with phenotypic traits in ALS, such as KIF5A rs113247976, which in our study is linked to an accelerated progression, could prove vital in forecasting the outcomes of treatment strategies and informing the selection of participants for forthcoming clinical trials and could enhance the power of the ENCALS Survival Prediction Model.